(Q34550147)

3 August 2017

1 reference

title

Innate immune recognition and suppression of tumors (English)

1 reference

3 August 2017

Mark J Smyth

2

0 references

author name string

Yoshihiro Hayakawa

series ordinal

1

1 reference

3 August 2017

publication date

1 January 2006

1 reference

Advances in Cancer Research

3 August 2017

published in

1 reference

3 August 2017

volume

95

1 reference

3 August 2017

page(s)

293-322

1 reference

Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Interferon-alpha in tumor immunity and immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

NKG2D-DAP10 triggers human NK cell–mediated killing via a Syk-independent regulatory pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Natural killer cells in antiviral defense: function and regulation by innate cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Human tumor antigens recognized by T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

IL-21 induces the functional maturation of murine NK cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Cancer: a biological approach. III. Viruses associated with neoplastic conditions. IV. Practical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Angiogenesis in cancer and other diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Ligands for natural killer cell receptors: redundancy or specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Natural killer cells, viruses and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Letal, A tumor-associated NKG2D immunoreceptor ligand, induces activation and expansion of effector immune cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

The Bcl-2 family: roles in cell survival and oncogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Differential antitumor immunity mediated by NKT cell subsets in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Spontaneous regression of advanced cancer: Identification of a unique genetically determined, age-dependent trait in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Cell death: critical control points

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Spontaneous development of plasmacytoid tumors in mice with defective Fas-Fas ligand interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

The intriguing role of polymorphonuclear neutrophils in antitumor reactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Cancer immunoediting: from immunosurveillance to tumor escape

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

The immunobiology of cancer immunosurveillance and immunoediting

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

The three Es of cancer immunoediting

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

A critical function for type I interferons in cancer immunoediting

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Gamma delta T cells provide an early source of interferon gamma in tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Reciprocal activating interaction between natural killer cells and dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Regulation of cutaneous malignancy by gammadelta T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

The distinct contributions of murine T cell receptor (TCR)gammadelta+ and TCRalphabeta+ T cells to different stages of chemically induced skin cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

NKT cells: facts, functions and fallacies.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

The Elusive NKT Cell Antigen--Is the Search Over?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

The pathophysiology of mitochondrial cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Endogenous type I interferons as a defense against tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Injection of mice with antibody to interferon enhances the growth of transplantable murine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Antibody to mouse interferon alpha/beta abrogates resistance to the multiplication of Friend erythroleukemia cells in the livers of allogeneic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Spontaneous and induced primary oncogenesis in natural killer (NK)-cell-deficient beige mutant mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Natural killer, but not natural killer T, cells play a necessary role in the promotion of an innate antitumor response induced by IL-18

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Alpha-galactosylceramide (KRN7000) suppression of chemical- and oncogene-dependent carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Alpha-galactosylceramide: potential immunomodulatory activity and future application

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Dlg, Scribble and Lgl in cell polarity, cell proliferation and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

The role of the NKG2D immunoreceptor in immune cell activation and natural killing

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Approaching the asymptote? Evolution and revolution in immunology

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Induction of tumor-specific T cell memory by NK cell–mediated tumor rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

A role for IFN-gamma in primary and secondary immunity generated by NK cell-sensitive tumor-expressing CD80 in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2-dependent T-cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

1 reference

7 January 2021

Defining a link with asthma in mice congenitally deficient in eosinophils.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Roles of heat-shock proteins in antigen presentation and cross-presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Natural killer (NK) cell function is a strong prognostic factor in colorectal carcinoma patients treated with the monoclonal antibody 17‐1A

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

In search of the 'missing self': MHC molecules and NK cell recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Intrinsic tumour suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Tumor suppressor genes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent process.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Tolerance, danger, and the extended family

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Constitutive expression of pore-forming protein in peripheral blood gamma/delta T cells: implication for their cytotoxic role in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

MHC class I recognition by Ly49 natural killer cell receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Interleukin 21: a key player in lymphocyte maturation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Natural born killers: NK cells drafted into the cancer fight

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Impairment of NK cell function by NKG2D modulation in NOD mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Does the immune system see tumors as foreign or self?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

The CD95(APO-1/Fas) DISC and beyond

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Roles of the NKG2D immunoreceptor and its ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

A new era for cancer immunotherapy based on the genes that encode cancer antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Progress in human tumour immunology and immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Human neoplasms elicit multiple specific immune responses in the autologous host

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Regulatory T cells: key controllers of immunologic self-tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Immunologic tolerance maintained by regulatory T cells: implications for autoimmunity, tumor immunity and transplantation tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Cutting Edge: Down-Regulation of MICA on Human Tumors by Proteolytic Shedding

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

The role of chemokine receptors in primary, effector, and memory immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Cancer/testis antigens: an expanding family of targets for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Response to 'A cancer immunosurveillance controversy'

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

CD4+ CD25+ suppressor T cells: more questions than answers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Molecular identification of a danger signal that alerts the immune system to dying cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Type I interferon and cancer immunoediting

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

NKT cells and tumor immunity—a double-edged sword

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Interleukin 2 induction of pore-forming protein gene expression in human peripheral blood CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Differential tumor surveillance by natural killer (NK) and NKT cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

NKT cells - conductors of tumor immunity?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

New aspects of natural-killer-cell surveillance and therapy of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Nature's TRAIL--on a path to cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Cytokines in cancer immunity and immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Activation of NK cell cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

NKG2D function protects the host from tumor initiation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

MICA and MICB genes: can the enigma of their polymorphism be resolved?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

How matrix metalloproteinases regulate cell behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Suppression of lymphoma and epithelial malignancies effected by interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and gammadelta T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Chemically induced sarcomas from nude mice are more immunogenic than similar sarcomas from congenic normal mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

IL-21 enhances tumor rejection through a NKG2D-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

A nonclassical non-Valpha14Jalpha18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Functional significance of the perforin/granzyme cell death pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Cell surface antigens of human renal cancer defined by autologous typing

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Decreased tumor surveillance in perforin-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Perforin dependence of natural killer cell-mediated tumor control in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Expression of stress-induced MHC class I related chain molecules on human melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

1 reference

7 January 2021

Human tumor antigens for cancer vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Cutting edge: novel priming of tumor-specific immunity by NKG2D-triggered NK cell-mediated tumor rejection and Th1-independent CD4+ T cell pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

An activating immunoreceptor complex formed by NKG2D and DAP10

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

TRAIL and its receptors as targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Cutting Edge: TRAIL Deficiency Accelerates Hematological Malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

Lysosomal glycosphingolipid recognition by NKT cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2995008-8

7 January 2021

10.1016/S0065-230X(06)95008-8

Identifiers

DOI

1 reference

3 August 2017

1 reference